Current Report Filing (8-k)

SECURITIES AND EXCHANGE COMMISSION

 

WASHINGTON, D.C.

 

FORM 8-K

 

CURRENT REPORT

 

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

 

_        September 1, 2020____

Date of Report (date of earliest event reported)

 

 

BIOMERICA, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware		001-37863		95-2645573
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification Number)

 

 

17571 Von Karman Ave.

Irvine, California 92614

(Address of Principal Executive Offices

Including Zip Code)

 

 

949-645-2111

(Registrant’s Telephone Number,

Including Area Code)

 

______________

(Former Name or Former Address if Changed

Since Last Report)

 

Page 1 of 2 pages

 

 

---

 

 

Item 7.01 Regulation FD Disclosure

 

 

     On September 1, 2020, Biomerica, Inc. (“the “Company”) presented an investor presentation to the investment community.  The investor presentation is attached hereto as Exhibit 99.1.

 

     The investor presentation is being furnished pursuant to General Instruction B.2 of Form 8-K and is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor is it subject to the liabilities of that section or deemed incorporated by reference in any filing by the Company under the Exchange Act unless specifically identified therein as being incorporated therein by reference.

 

Item 9.01  Financial Statements and Exhibits

 

(d)  Exhibits

 

Exhibit

Number           Description

 

99.1                 Investor Presentation

 

 

 

SIGNATURES

 

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Dated:  September 2, 2020			Biomerica, Inc.
			By:	/s/ Zackary S. Irani
			Zackary S. Irani
			Chief Executive Officer